Taylor PC - Search Results

1

Tumour necrosis factor alpha as a therapeutic target for immune-mediated inflammatory diseases.

Taylor PC, Williams RO, Feldmann M. Taylor PC, et al. Curr Opin Biotechnol. 2004 Dec;15(6):557-63. doi: 10.1016/j.copbio.2004.09.005. Curr Opin Biotechnol. 2004. PMID: 15560982 Review.

2

HER2 (c-erbB-2) oncoprotein expression in colorectal adenocarcinoma: an immunohistological study using three different antibodies.

Arnaout AH, Dawson PM, Soomro S, Taylor P, Theodorou NA, Feldmann M, Fendly BM, Shepard HM, Shousha S. Arnaout AH, et al. J Clin Pathol. 1992 Aug;45(8):726-7. doi: 10.1136/jcp.45.8.726. J Clin Pathol. 1992. PMID: 1357006 Free PMC article.

3

c-erbB-2 expression in different histological types of invasive breast carcinoma.

Soomro S, Shousha S, Taylor P, Shepard HM, Feldmann M. Soomro S, et al. J Clin Pathol. 1991 Mar;44(3):211-4. doi: 10.1136/jcp.44.3.211. J Clin Pathol. 1991. PMID: 1672872 Free PMC article.

4

Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.

Maini RN, Elliott MJ, Brennan FM, Williams RO, Chu CQ, Paleolog E, Charles PJ, Taylor PC, Feldmann M. Maini RN, et al. Among authors: taylor pc. Immunol Rev. 1995 Apr;144:195-223. doi: 10.1111/j.1600-065x.1995.tb00070.x. Immunol Rev. 1995. PMID: 7590814 Review.

5

c-erbB-2 oncoprotein in screen-detected breast carcinoma: an immunohistological study.

Soomro S, Taylor P, Shepard HM, Feldmann M, Sinnett HD, Shousha S. Soomro S, et al. Int J Cancer. 1993 Aug 19;55(1):63-5. doi: 10.1002/ijc.2910550112. Int J Cancer. 1993. PMID: 8102130

6

Humoral and cellular responses raised against the human HER2 oncoprotein are cross-reactive with the homologous product of the new proto-oncogene, but do not protect rats against B104 tumors expressing mutated neu.

Taylor P, Gerder M, Moros Z, Feldmann M. Taylor P, et al. Cancer Immunol Immunother. 1996 Mar;42(3):179-84. doi: 10.1007/s002620050268. Cancer Immunol Immunother. 1996. PMID: 8640846 Free PMC article.

7

Effect of blocking TNF on IL-6 levels and metastasis in a B16-BL6 melanoma/mouse model.

Cubillos S, Scallon B, Feldmann M, Taylor P. Cubillos S, et al. Anticancer Res. 1997 May-Jun;17(3C):2207-11. Anticancer Res. 1997. PMID: 9216689

8

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.

Feldmann M, Brennan F, Paleolog E, Taylor P, Maini RN. Feldmann M, et al. Eur Cytokine Netw. 1997 Sep;8(3):297-300. Eur Cytokine Netw. 1997. PMID: 9346366 Free article. Review. No abstract available.

9

Biological insights from clinical trials with anti-TNF therapy.

Feldmann M, Charles P, Taylor P, Maini RN. Feldmann M, et al. Springer Semin Immunopathol. 1998;20(1-2):211-28. doi: 10.1007/BF00832008. Springer Semin Immunopathol. 1998. PMID: 9836378 No abstract available.

10

Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases.

Feldman M, Taylor P, Paleolog E, Brennan FM, Maini RN. Feldman M, et al. Transplant Proc. 1998 Dec;30(8):4126-7. doi: 10.1016/s0041-1345(98)01365-7. Transplant Proc. 1998. PMID: 9865320 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters